Cargando…

Should We Consider the Cardiovascular System While Evaluating CKD-MBD?

Cardiovascular (CV) disease is highly prevalent in the population with chronic kidney disease (CKD), where the risk of CV death in early stages far exceeds the risk of progression to dialysis. The presence of chronic kidney disease-mineral and bone disorder (CKD-MBD) has shown a strong correlation w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rroji, Merita, Figurek, Andreja, Spasovski, Goce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150959/ https://www.ncbi.nlm.nih.gov/pubmed/32106499 http://dx.doi.org/10.3390/toxins12030140

Ejemplares similares

The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu
por: Figurek, Andreja, et al.
Publicado: (2021)

FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia
por: Figurek, Andreja, et al.
Publicado: (2023)

Proteomic Approaches and Potential Applications in Autosomal Dominant Polycystic Kidney Disease and Fabry Disease
por: Rroji, Merita, et al.
Publicado: (2023)

Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney Disease
por: Rroji, Merita, et al.
Publicado: (2022)

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?
por: Vervloet, Marc G
Publicado: (2023)

A Japanese approach for CKD-MBD
por: Yokoyama, Keitaro, et al.
Publicado: (2013)

Magnesium—A More Important Role in CKD–MBD than We Thought
por: Peride, Ileana, et al.
Publicado: (2022)

CKD-MBD after kidney transplantation
por: Wesseling-Perry, Katherine, et al.
Publicado: (2011)

Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
por: Yamada, Shunsuke, et al.
Publicado: (2023)

Prevention and Treatment of CKD-MBD
por: Cozzolino, Mario
Publicado: (2013)

The Role of Vitamin K in CKD-MBD
por: Fusaro, Maria, et al.
Publicado: (2022)

CKD-MBD diagnosis: biochemical abnormalities
por: Lucca, Leandro Junior, et al.
Publicado: (2021)

Gaps between Global Guidelines and Local Practices in CKD-MBD
por: Kim, Gheun-Ho
Publicado: (2014)

Which Vitamin D in CKD-MBD? The Time of Burning Questions
por: Galassi, Andrea, et al.
Publicado: (2013)

Clinical significance of parathyroid intervention on CKD-MBD management
por: Ogata, Hiroaki, et al.
Publicado: (2008)

Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges
por: Zoccali, Carmine, et al.
Publicado: (2021)

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
por: Waziri, Bala, et al.
Publicado: (2019)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

CKD-MBD in Brazil: the gap between reality and the recommended guidelines
por: Custódio, Melani Ribeiro
Publicado: (2018)

Diagnosis of bone abnormalities in CKD-MBD (Imaging and bone biopsy)
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2021)

The Influence of Dietary Interventions on Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
por: Rysz, Jacek, et al.
Publicado: (2021)

Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study
por: Magagnoli, Lorenza, et al.
Publicado: (2023)

Testing Patterns for CKD-MBD Abnormalities in a Sample US Population
por: Wetmore, James B., et al.
Publicado: (2021)

Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease
por: Kaur, Rupinder, et al.
Publicado: (2023)

Improvement in kidney transplantation in the Balkans after the Istanbul Declaration: where do we stand today?
por: Spasovski, Goce, et al.
Publicado: (2016)

The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study
por: Locatelli, Francesco, et al.
Publicado: (2014)

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015
por: Hamano, Takayuki
Publicado: (2017)

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
por: Behets, Geert J., et al.
Publicado: (2017)

Effects of diuretics furosemide and hydrochlorothiazide on CKD-MBD: A prospective randomized study
por: Vasco, Raquel F.V., et al.
Publicado: (2021)

What We Should Consider for Full Densification when Sintering
por: Kang, Suk-Joong L.
Publicado: (2020)

Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease–Metabolic Bone Disease (CKD-MBD)
por: Rodriguez, Mariano, et al.
Publicado: (2018)

The Use of Imaging Techniques in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)—A Systematic Review
por: Pimentel, Ana, et al.
Publicado: (2021)

Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients
por: Hafez, Gaye, et al.
Publicado: (2023)

Introduction: expanding concepts of chronic kidney disease-mineral and bone disorder (CKD-MBD)
por: Fukagawa, Masafumi, et al.
Publicado: (2013)

Should we consider the infusion of lipid emulsion in the resuscitation of poisoned patients?
por: Cave, Grant, et al.
Publicado: (2014)

Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD
por: Burton, James O., et al.
Publicado: (2018)

Evaluation of a Pharmacist–Dietician-Led Patient-Centered Approach to Managing CKD-MBD: A Mixed-Method Study
por: Baker, Tamara, et al.
Publicado: (2020)

Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan
por: Fukuma, Shingo, et al.
Publicado: (2013)

Erythema nodosum: what should we consider about it?
por: Babamahmoudi, Farhang, et al.
Publicado: (2016)

NephroCheck: should we consider urine osmolality?
por: Noto, Alberto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7hbhn2p6252hpqmh4jcud95sd7